Physician profile
Todd Baker
NPI 1871758870
$14,879.16
in general payments reported to CMS, 2019-2025
26 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $40.01 · 2021: $122 · 2022: $525 · 2023: $1,230 · 2024: $1,634 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,000 · Consulting Fee: $5,360 · Food and Beverage: $1,717 · Travel and Lodging: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,000.00 |
| Consulting Fee | $5,360.33 |
| Food and Beverage | $1,716.61 |
| Travel and Lodging | $647.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $6,879.97 | 2024-2025 | Cohealyx, Permeaderm, Recell |
| Ethicon US, LLC | $3,392.19 | 2022-2025 | Vistaseal |
| Abbvie INC. | $1,979.02 | 2023-2024 | Botox, Natrelle Saline-Filled Breast Implants |
| Becton, Dickinson and Company | $705.83 | 2022-2025 | |
| Covidien LP | $420.00 | 2019 | |
| Mentor Worldwide LLC | $221.56 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $211.64 | 2025 | |
| Mimedx Group, INC. | $185.60 | 2024-2025 | |
| Rti Surgical, INC | $124.99 | 2025 | |
| Integra Lifesciences Corporation | $124.07 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Vertex Pharmaceuticals Incorporated | $117.50 | 2024-2025 | |
| Allergan, INC. | $81.51 | 2019-2022 | |
| Davol INC. | $66.16 | 2024 | Phasix Mesh |
| Musculoskeletal Transplant Foundation INC. | $52.61 | 2023-2024 | |
| Axogen | $51.51 | 2023-2025 | Avance Nerve Graft |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $43.56 | 2022 | |
| Smith+Nephew, INC. | $43.11 | 2024-2025 | Stravix Pl |
| Surgenex LLC | $32.18 | 2025 | Renograft, Pellograft, Surmatrix |
| Innovation Technologies INC | $22.67 | 2022 | |
| Tela Bio, INC. | $21.18 | 2024 | Ovitex 2s |
| Aroa Biosurgery Incorporated | $20.20 | 2024 | |
| Coopersurgical, INC. | $19.55 | 2025 | Onetrac Lx |
| Polynovo North America LLC | $17.66 | 2021 | |
| Kci USA, INC. | $15.56 | 2021 | |
| Sanara Medtech INC. | $15.35 | 2025 | Celleraterx |
| Tei Biosciences INC | $13.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.